From January 1, 2024 to March 31, 2024, the company has repurchased 55,500 shares, representing 0.11% for $0.52 million. With this, the company has completed the repurchase of 3,048,548 shares, representing 5.64% for $28.62 million under the buyback announced on December 6, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.57 USD | +15.06% |
|
+27.02% | +54.75% |
10/07 | Nephron Initiates CareDx at Hold Rating With $15 Price Target | MT |
01/07 | CareDx, Inc(NasdaqGM:CDNA) added to Russell 3000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.75% | 84Cr | |
-32.86% | 868.21Cr | |
+25.06% | 385.95Cr | |
+15.74% | 242.89Cr | |
-26.46% | 183.93Cr | |
-7.09% | 172.7Cr | |
+40.61% | 116.36Cr | |
-9.17% | 70Cr | |
-9.18% | 59Cr | |
-19.58% | 24Cr |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- Tranche Update on CareDx, Inc's Equity Buyback Plan announced on December 6, 2022.